Discover how decentralized manufacturing is reshaping the landscape of cell and gene therapy development in this blog capturing insights from our Bridging the Gap webinar series. Gain valuable insights from experts like Dorothea Ledergerber, PhD, Chief Technical Officer at Tigen Pharma, and Patrick Hanley, PhD, Director of the Cellular Therapy Program at Children’s National Hospital. Read the full blog and register for future webinars here: https://hubs.ly/Q02xHWy70 #CellTherapy #GeneTherapy #Innovation #WebinarSeries
Azenta Life Sciences’ Post
More Relevant Posts
-
Come join Senthil Ramaswamy and I as we discuss the critical needs for the future of Cell and Gene Therapies
Join us on June 13 for an insightful webinar on the revolutionary innovations that are shaping the cell and gene therapy manufacturing space. In this webinar, we will explore the complex landscape of process development and analytical development, while reviewing key focus areas based on lessons learned across our experiences. The discussion will be framed around where the market is headed and how breakthroughs will make for a bright future. Register today on https://lnkd.in/gKutKXGY Date: Thursday, June 13, 2024 Time: 11am EDT | 5pm CET Speaker: Mark Santos, Global Head of Commercial Development and Strategic Marketing, Cell & Gene Technologies #celltherapy #genetherapy #LonzaCGT #RealizingPotentialTogether
-
-
It was a pleasure to sit down with Fierce Biotech to share my thoughts on the state of the cell and gene industry and the pivotal role that the cold chain is playing in it's progression. Watch the video below: #cellandgene #SupplyChainSolutions #ColdChain #TemperatureControl #PharmaSupplyChain #Logistics #Sustainability #Cryo
How are current innovations shaping the future of cell and gene therapies and cold chain logistics? "This interview explores the increasing demand for real-time visibility technologies and high-performance shipping solutions. Emilio Frattaruolo, CPPL, VP of Cell and Gene Therapies, highlights the importance of thinking holistically about supply chains, from early-stage research through to commercialization and scaling up for larger patient populations." Watch it now! ➡️ https://hubs.li/Q02HP7Fl0 #CellAndGeneTherapies #ColdChainLogistics #PharmaSupplyChain Fierce Biotech
-
-
Modular facilities, driven by the rise of cell and gene therapies, continuous manufacturing, and single-use technologies, help biomanufacturers meet clinical demands. Learn how we partnered with Siemens to create automation and digitization solutions for streamlined modular processing. Watch the video below and learn more in our white paper: https://sar.to/1xs07 #SimplifyingProgress #InThisTogether #Bioprocessing
-
In an industry where change is ever constant, Andelyn Biosciences stands as your steadfast partner in gene therapy manufacturing. With over two decades of experience and expertise, our commitment to growth and innovation ensures we're here for you, ready to bring your groundbreaking therapies from the lab to the patient. See what a feasibility study and yield assessment can do to get your program started on a path to process industrialization: https://buff.ly/3UzqzNP #andelynbiosciences
-
-
🚀 Boost Your Biopharma & Gene Therapy IQ! 🧬 Whether you’re just starting out or you’re a seasoned pro, our glossary is your go-to guide for all things biopharmaceuticals and gene therapy. Perfect for scientists, researchers, and business execs alike! 📚 Download the eBook now: https://bit.ly/4cu4UO5
-
-
Interesting article regarding the future of cell and gene therapies and the cold chain logistics they require. Our VP of Cell and Gene Therapies Emilio Frattaruolo, CPPL is always happy to discuss your specific requirements!
How are current innovations shaping the future of cell and gene therapies and cold chain logistics? "This interview explores the increasing demand for real-time visibility technologies and high-performance shipping solutions. Emilio Frattaruolo, CPPL, VP of Cell and Gene Therapies, highlights the importance of thinking holistically about supply chains, from early-stage research through to commercialization and scaling up for larger patient populations." Watch it now! ➡️ https://hubs.li/Q02HP7Fl0 #CellAndGeneTherapies #ColdChainLogistics #PharmaSupplyChain Fierce Biotech
-
-
Engaging discussion on the challenges, emerging trends, and key value drivers shaping the Cell & Gene Therapy (C>) space, as well as the potential growth opportunities in Europe at Advanced Therapies Europe 2024. At Invivo Partners, we’re confident that the C> field will continue to advance, with promising expansions into new indications, the exploration of novel cell types, and the development of cutting-edge technologies to tackle the challenges ahead. #ATE24
-
-
The journey from scientific discovery to commercial success in cell and gene therapy is full of challenges. These challenges were the focus of a recent panel at the #PharmaLifeSciences2024: Advancements in Cell and Gene Therapy virtual summit, featuring Likarda CEO, Dr. Stella K. Vnook. Key topics included scaling production, patient engagement, and navigating regulatory hurdles—along with strategies to overcome them. Thank you to TechTarget for summarizing this insightful discussion, which you can read here: https://lnkd.in/gpreEJes #CellTherapy #GeneTherapy #HealthcareInnovation #Biotech
-
-
📢 Don't miss tomorrow's Cell & Gene Therapy Insights’ webinar on unlocking success in CAR T tech transfer, featuring expert panelists, Sara Mills at Dark Horse Consulting Group Inc., Neil Blackburn at OmniaBio, and Dan Miskimin at BrainChild Bio. Register today: https://lnkd.in/gJbqp7T9 Key topics: ➡️ Discuss typical obstacles encountered in tech transfer and how to proactively address them. ➡️ Discover how to master the CAR T cell therapy tech transfer process. ➡️ Learn from a real-world case study showing how to achieve seamless transition to GMP manufacturing. #CellandGeneTherapy #CellTherapy #GeneTherapy #Webinar
-
-
One week to go until the experts in market access, regulatory affairs, and non-clinical strategy at the Cell and Gene Therapy Catapult will be delivering a webinar on 'Developing a robust target product profile (TPP) for successful therapy adoption'. If you are looking to improve your understanding of the characteristics of a TPP, attending this webinar is essential to learn how to create your own robust #TPP and increase the likelihood of successful adoption of your #AdvancedTherapy. Learn more: https://buff.ly/3RqT2nC ##TPP #CGTDeveloper #CellTherapies #GeneTherapies
-
